Workflow
Aclaris Therapeutics (ACRS) Earnings Call Presentation

ATI-2138 Phase 2a Top-Line Results July 29, 2025 Disclaimer and Cautionary Note Regarding Forward -Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "anticipate," "believe," "expect," "intend," "may," "plan," "potential," "will," and similar expressions, and are based on Aclaris' cu ...